687 related articles for article (PubMed ID: 27651161)
1. RAD51B as a potential biomarker for early detection and poor prognostic evaluation contributes to tumorigenesis of gastric cancer.
Cheng Y; Yang B; Xi Y; Chen X
Tumour Biol; 2016 Nov; 37(11):14969-14978. PubMed ID: 27651161
[TBL] [Abstract][Full Text] [Related]
2. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
[TBL] [Abstract][Full Text] [Related]
3. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D
World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474
[TBL] [Abstract][Full Text] [Related]
4. CDCA3 is a potential prognostic marker that promotes cell proliferation in gastric cancer.
Zhang Y; Yin W; Cao W; Chen P; Bian L; Ni Q
Oncol Rep; 2019 Apr; 41(4):2471-2481. PubMed ID: 30816466
[TBL] [Abstract][Full Text] [Related]
5. Upregulated expression of long non-coding RNA LINC00982 regulates cell proliferation and its clinical relevance in patients with gastric cancer.
Fei ZH; Yu XJ; Zhou M; Su HF; Zheng Z; Xie CY
Tumour Biol; 2016 Feb; 37(2):1983-93. PubMed ID: 26334618
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16.
Kong R; Zhang EB; Yin DD; You LH; Xu TP; Chen WM; Xia R; Wan L; Sun M; Wang ZX; De W; Zhang ZH
Mol Cancer; 2015 Apr; 14():82. PubMed ID: 25890171
[TBL] [Abstract][Full Text] [Related]
7. TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis.
Zhou Y; Huang T; Zhang J; Wong CC; Zhang B; Dong Y; Wu F; Tong JHM; Wu WKK; Cheng ASL; Yu J; Kang W; To KF
Oncogene; 2017 Nov; 36(47):6518-6530. PubMed ID: 28759040
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of heat shock factor 1 (HSF1) is associated with poor survival in gastric cancer patients.
Dai W; Ye J; Zhang Z; Yang L; Ren H; Wu H; Chen J; Ma J; Zhai E; Cai S; He Y
Diagn Pathol; 2018 Oct; 13(1):80. PubMed ID: 30326922
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA SPRY4-IT1 predicts poor patient prognosis and promotes tumorigenesis in gastric cancer.
Peng W; Wu G; Fan H; Wu J; Feng J
Tumour Biol; 2015 Sep; 36(9):6751-8. PubMed ID: 25835973
[TBL] [Abstract][Full Text] [Related]
11. Nuclear PRMT1 expression is associated with poor prognosis and chemosensitivity in gastric cancer patients.
Altan B; Yokobori T; Ide M; Mochiki E; Toyomasu Y; Kogure N; Kimura A; Hara K; Bai T; Bao P; Suzuki M; Ogata K; Asao T; Nishiyama M; Oyama T; Kuwano H
Gastric Cancer; 2016 Jul; 19(3):789-97. PubMed ID: 26472729
[TBL] [Abstract][Full Text] [Related]
12. Lentivirus-mediated shRNA targeting of cyclin D1 enhances the chemosensitivity of human gastric cancer to 5-fluorouracil.
Seo JH; Jeong ES; Lee KS; Heo SH; Jeong DG; Choi YK
Int J Oncol; 2013 Dec; 43(6):2007-14. PubMed ID: 24100731
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of miR-601 is associated with poor prognosis and tumor progression of gastric cancer.
Min C; Zhang A; Qin J
Diagn Pathol; 2019 Sep; 14(1):107. PubMed ID: 31547835
[TBL] [Abstract][Full Text] [Related]
14. Clinical Significance of Myeloid Zinc Finger 1 Expression in the Progression of Gastric Tumourigenesis.
Li GQ; He Q; Yang L; Wang SB; Yu DD; He YQ; Hu J; Pan YM; Wu Y
Cell Physiol Biochem; 2017; 44(3):1242-1250. PubMed ID: 29179204
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of miR-181d is associated with poor prognosis and tumor progression of gastric cancer.
Li Z; Guo Q; Lu Y; Tian T
Cancer Biomark; 2019; 26(3):353-360. PubMed ID: 31524144
[TBL] [Abstract][Full Text] [Related]
16. SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma.
Liu Y; Luo X; Deng J; Pan Y; Zhang L; Liang H
Tumour Biol; 2015 Apr; 36(4):2685-94. PubMed ID: 25472580
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of long non-coding RNA PCAT-1 correlates with tumor progression and poor prognosis in gastric cancer.
Cui WC; Wu YF; Qu HM
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(13):3021-3027. PubMed ID: 28742205
[TBL] [Abstract][Full Text] [Related]
18. Expression characteristics of CDC20 in gastric cancer and its correlation with poor prognosis.
Ding ZY; Wu HR; Zhang JM; Huang GR; Ji DD
Int J Clin Exp Pathol; 2014; 7(2):722-7. PubMed ID: 24551295
[TBL] [Abstract][Full Text] [Related]
19. Serum angiopoietin-like protein 2 as a potential biomarker for diagnosis, early recurrence and prognosis in gastric cancer patients.
Toiyama Y; Tanaka K; Kitajima T; Shimura T; Imaoka H; Mori K; Okigami M; Yasuda H; Okugawa Y; Saigusa S; Ohi M; Inoue Y; Mohri Y; Goel A; Kusunoki M
Carcinogenesis; 2015 Dec; 36(12):1474-83. PubMed ID: 26420253
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of polypyrimidine tract-binding protein 3 induces apoptosis and cell cycle arrest, and enhances the cytotoxicity of 5- fluorouracil in gastric cancer cells.
Liang X; Shi H; Yang L; Qiu C; Lin S; Qi Y; Li J; Zhao A; Liu J
Br J Cancer; 2017 Mar; 116(7):903-911. PubMed ID: 28222070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
